West Pharmaceutical Services, Inc. (WST) Earnings Call Analysis

NYSE · Healthcare · Medical Instruments & Supplies

23/25

Growth 5 Margin 5 Expansion 5 Platform 3 Financial 5

latest quarter score

Earnings Reports

23
West Pharmaceutical (WST) Q2 2026: HVP Components Surge 18%, Driving Guidance Lift and Margin Expansion
July 24, 2026
24
West Pharmaceutical (WST) Q4 2025: HVP Components Surge 15%, Driving Margin Expansion and Multi-Year Growth Visibility
June 15, 2026
23
West Pharmaceutical (WST) Q1 2026: HVP Components Surge 23%, Margin Expansion Signals Multi-Year Tailwind
April 23, 2026
23
West Pharmaceutical (WST) Q3 2025: HVP Components Surge 13%, Fueling Upward Guidance and Margin Expansion
October 27, 2025
24
West Pharmaceutical (WST) Q2 2025: HVP Components Up 11%, Biologics and Annex 1 Drive Multi-Year Tailwind
July 24, 2025
23
West Pharmaceutical (WST) Q1 2025: GLP-1 Revenue Hits 7% of Total, Driving HVP Segment Momentum
July 07, 2025

Browse all companies